1 / 65

David B. Warheit, Ph.D. DuPont Haskell Laboratory

Potential for Bio-uptake and Bioaccumulation of Nanotechnology Particles: Impact of Carbon Nanotube Exposures in the Lung. David B. Warheit, Ph.D. DuPont Haskell Laboratory IOM – Implications of Nanotechnology May 27, 2004. Outline. Lung structure and particle deposition

sheera
Download Presentation

David B. Warheit, Ph.D. DuPont Haskell Laboratory

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Potential for Bio-uptake and Bioaccumulation of Nanotechnology Particles: Impact of Carbon Nanotube Exposures in the Lung David B. Warheit, Ph.D. DuPont Haskell Laboratory IOM – Implications of Nanotechnology May 27, 2004

  2. Outline • Lung structure and particle deposition • Pulmonary bioassay as a measure of bioaccumulation • Pulmonary bioassay with single wall carbon nanotubes • Preliminary results with Fine/Nano- scale quartz, Fine/Nanoscale TiO2 dots and rods, Fine and Nano ZnO • Summary

  3. Definitions- Particle Size • Nano = Ultrafine = < 100 nm • Fine = 100 nm - 3 m • Respirable (rat) = < 3 m (max = 5 m) • Respirable (human) = < 5 m (max = 10 m) • Inhalable (human) = ~ 10 - 50 m

  4. Particle Scale PM 10 Ultrafine Respirable PM 2.5 Nanoparticles 10 mm 1 mm 1 nm 10 nm 100 nm

  5. Rat Lung Microdissection

  6. Rat Lung Tissue Dissected to Demonstrate the Junction of the Terminal Airway and Proximal Alveolar Region

  7. Iron Particle Deposition at Bronchoalveolar Junction

  8. Iron Particle Deposition at Bronchoalveolar Junction(Backscatter Image)

  9. Interparticle Forces(Aggregates & Agglomerates) Mechanical interlocking Single particle Capillary (surface tension) Van der Waals (cohesive force α 1/d**2) Chemical bonds Equivalent dia. ~2 x Settling velocity ~3-4 x Equivalent diameters of 10-1000x are common

  10. Alveolar Macrophage Clearance of Inhaled Iron Particles

  11. Alveolar Macrophage Clearance of Inhaled Iron Particles(Backscatter Image)

  12. Alveolar Macrophage Migration to Iron Particle Deposition and Phagocytosis

  13. Alveolar Macrophage Migration to Iron Particle Deposition and Phagocytosis(Backscatter Image)

  14. Clearance of Iron Particles on the Airway Mucociliary Escalator

  15. Clearance of Iron Particles on the Airway Mucociliary Escalator

  16. Morphometry at Bronchoalveolar Junctions

  17. Cytocentrifuge Preparation of BAL – Recovered Cells From a Sham – Exposed Rat

  18. Cytocentrifuge Preparation of BAL – Recovered Cells From a Quartz (Crystalline Silica) – Exposed Rat

  19. External Perceptions on Pulmonary Toxicity of Nanoparticles • Nanoparticles are more toxic (inflammogenic, tumorigenic) than fine-sized particles of identical composition. • Concept generally based on 3 particle-types: • Titanium Dioxide particles • Carbon Black particles • Diesel Particles

  20. Complications related to the Dogma of Nanoparticulate Toxicology • Not all Nanoparticles are more toxic • Surface coatings of particles • Coatings - passivated or dispersion • Species Differences in Lung Responses • Rat is the most sensitive species • Particle aggregation/disaggregation potential • Fumed vs. precipitated Nanoparticles • Surface charge of particles

  21. Pulmonary Bioassay Studies • Working hypothesis • Four factors influence the development of pulmonary fibrosis • inhaled materials which cause cell/lung injury • inhaled materials which promote ongoing inflammation • inhaled materials which reduce alveolar macrophage function • inhaled materials which persist in the lung

  22. Pulmonary Toxicity Screening Studies with Single Wall Carbon Nanotubes DB Warheit, BR Laurence, KL Reed, DH Roach*, GAM Reynolds*, G Joseph*, and TR Webb DuPont Haskell Laboratory for Health and Environmental Sciences, Newark, DE and *DuPont Company, Wilmington, DE

  23. Objective • The objective of this pulmonary bioassay study was to evaluate, using a bridging methodology, the acute lung toxicity of intratracheally instilled single wall carbon nanotubes (CNT) in rats when compared to positive and negative particle controls. • Nanoparticles are considered to be more hazardous when compared to fine-sized particles of identical chemical composition.

  24. Some Possible Uses for Carbon Nanotubes • Transistors and diodes • Field emitter for flat-panel displays • Cellular-phone signal amplifier • Ion storage for batteries • Materials strengthener Source: Scientific American- Illustration: RICHARD E. SMALLEY, Rice University

  25. Pulmonary Bioassay Components • Bronchoalveolar Lavage Assessments • Lung Inflammation & Cytotoxicity • Cell Differential Analysis • BAL Fluid Lactate Dehydrogenase (cytotoxicity) • BAL Fluid Alkaline Phosphatase (epithelial cell toxicity) • BAL Fluid Protein (lung permeability) • Lung Tissue Analysis • Lung Weights • Lung Cell Proliferation (BrdU) • Parenchymal • Airway • Lung Histopathology

  26. Pulmonary Bioassay BrdU via IP Phosphate Buffered Saline Cellular Inflammation Bronchoalveolar Lavage Fluid Lavage Chemistry

  27. Parameter BALF Cells and Differentials BALF Lactate Dehydrogenase BALF Alkaline Phosphatase BALF Protein Lung Weights Macrophage phagocytosis Cell Proliferation Histopathology Indicator Lung Inflammation Non-specific cytotoxicity Type 2 cell epithelial toxicity Permeability  of alveolar/ capillary barrier Pulmonary edema or fibrosis Lung clearance functions Inflammation/lung fibrosis and tumor potential Evaluation of lung tissue responses Use of Bronchoalveolar Lavage, Cell Proliferation, and Histopathology to Assess the Lung Toxicity of CNT samples (BALF = Bronchoalveolar Lavage Fluid Analysis)

  28. Protocol for Carbon Nanotube Bioassay Study Intratracheal Instillation Exposure Doses of 1 and 5 mg/kg • Exposure Groups • PBS (control) • PBS-Tween 80 (control) • Particulate Types (1 and 5 mg/kg) • Carbon Nanotubes • Quartz Particles (positive control) • Carbonyl Iron Particles (negative control) • Graphite (carbon particle control) Instillation Exposure Postexposure Evaluation via BAL and Lung Tissue 24 hr 1 wk 1 mo 3 mo

  29. Pulmonary Bioassay Bridging Studies Inhalation Studies Carbonyl Iron Particles Quartz Particles Intratracheal Instillation Studies PBS Tween Sham Carbonyl Iron Particles Carbon Nanotube Particles Quartz Particles vs vs vs

  30. RESULTS

  31. Light micrograph of lung tissue from a rat exposed to 5 mg/kg CNT (a few hours after exposure). The major airways are mechanically blocked by the CNT instillate. This lead to suffocation in 15% of the CNT-exposed rats and was not evidence of pulmonary toxicity of CNT.

  32. Light micrograph of lung tissue from a rat exposed to 5 mg/kg CNT (a few hours after exposure). The major airways are mechanically blocked by the CNT instillate. This lead to suffocation in 15% of the CNT-exposed rats and was not evidence of pulmonary toxicity of CNT.

  33. Bronchoalveolar Lavage Fluid Results

  34. Pulmonary inflammation in particulate-exposed rats and controls as evidenced by % neutrophils (PMN) in BAL fluids at 24 hrs, 1 week, 1 month and 3 months postexposure (pe). Instillation exposures resulted in transient inflammatory responses for nearly all groups at 24 hrs pe. However, exposures to Quartz particles at 1 and 5 mg/kg produced a sustained lung inflammatory response. p < 0.05

  35. BAL fluid LDH values for particulate-exposed rats and corresponding controls at 24 hrs, 1 week, 1 month and 3 months postexposure (pe). Significant increases in BALF LDH vs. controls were measured in the CNT 5 mg/kg exposed group at 24 hrs pe and the 5 mg/kg Quartz-exposed animals at all 4 time periods pe. p < 0.05.

  36. Lung Tissue Results LungHistopathologyStudies

  37. Carbonyl Iron particles - 1 Month postexposure

  38. Quartz particles - 1 Month postexposure

  39. Quartz particles - 1 Month postexposure

  40. Quartz particles - 3 Months postexposure

  41. CNT - 1 Week postexposure

  42. CNT - 1 Month postexposure

  43. CNT - 1 Month postexposure

  44. Conclusions from Instillation Studies • Intratracheal instillation exposures in rats to CNT (5 mg/kg) produced ~15% mortality. • Further investigation of this finding demonstrated that following instillation of the dispersed CNT suspension (with PBS and Tween), the CNT agglomerated in the main airways and the rats died from suffocation – not CNT toxicity.

  45. Conclusions from Bronchoalveolar Lavage Study • Pulmonary exposures to Quartz particles produced a sustained, dose-dependent lung inflammatory response measured from 24 hrs  3M postexposure. • Exposures to CNT (5 mg/kg) produced a transient pulmonary inflammatory response at 24 hrs but was not sustained. • Exposures to Carbonyl Iron produced a brief neutrophilic lung response – related to the instillation exposure.

  46. Observations on CNT- induced Lung Lesions • Multifocal granulomas consisted of macrophage-like multinucleate giant cells – foreign body rxn • Granulomatous lesions appeared to be associated with a black CNT bolus • Distribution of lesions - not consistent in lung lobes • No apparent dose response relationship • Possible regression with time 1M  3M • Not consistent with ADBF paradigm – unlike silica/asbestos or other dust-related lesions • BAL results were not predictive of this lesion • Likely affected by route of exposure? – instillation of CNT bolus?

  47. Exposure to carbon nanotube material: Aerosol release during the handling of unrefined SWCNT- Andrew Maynard et al. • Laboratory study and field-based study • Field study – assessed airborne and dermal exposure to SWCNT while handling unrefined material. • Lab studies – SWCNT can release fine particles with sufficient agitation. • Field studies – concentrations generated while handling material were very low- always < 53 g/m3.

  48. Handling nanotube material Raw single walled nanotube material

  49. Unique structures and morphologies Carbon Nanotubes

  50. Case Study Health risk associated with carbon nanotube production

More Related